GMILogo_Vertical-Gradient.png
Drug-Eluting Balloon Catheters Market to hit USD 916 Million by 2028, Says Global Market Insights Inc.
April 13, 2022 07:15 ET | Global Market Insights Inc.
Selbyville, Delaware, April 13, 2022 (GLOBE NEWSWIRE) -- Global drug-eluting balloon catheters market value is anticipated to reach USD 916 million by 2028, according to a new research report by...
Global Ovarian Cancer Drugs Market
Global Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others
March 29, 2022 05:23 ET | Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2022, Tumor Type, Distribution Channel, Drug Type" report has been added to ResearchAndMarkets.com's...
22157.jpg
Investigation Report on China's CNY1.112 Billion Docetaxel Market 2021-2025
December 31, 2021 05:43 ET | Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Docetaxel Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to the market...
22157.jpg
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
October 22, 2021 04:53 ET | Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
fior-markets-logo.jpg
Global Drug-Eluting Bioabsorbable Stents Market Is Expected to Reach USD 579.87 Million by 2027 : Fior Markets
September 29, 2020 19:00 ET | Fior Markets
Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global drug-eluting bioabsorbable stents market is expected to grow from USD 393.31 million in 2019...
Calithera_Logo_Primary_RGB_M01.jpg
Updated Results from Phase I Study of CB-839 in Combination with Paclitaxel in Patients with Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium
December 05, 2017 08:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small...